Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries

Documenti analoghi

• Updated Epidemiology of Gastrointestinal Cancers in the Asia‐Pacific: Evidence From GBD 2021 and GLOBOCAN 2022
  di: Primrose Tothanarungroj, et al.
  Pubblicazione: (2026)
• Sex disparities in global burden of gallbladder and biliary tract cancer: analysis of Global Burden of Disease study from 2010 to 2019
  di: Priyata Dutta, et al.
  Pubblicazione: (2024)
• Alcohol–Related Liver Disease, Followed by Metabolic Dysfunction–Associated Steatotic Liver Disease, Emerges as the Fastest‐Growing Aetiologies for Primary Liver Cancer in the United States
  di: Pojsakorn Danpanichkul, et al.
  Pubblicazione: (2025)
• Global epidemiology of early‐onset upper gastrointestinal cancer: trend from the Global Burden of Disease Study 2019
  di: Pojsakorn Danpanichkul, et al.
  Pubblicazione: (2024)
• Effect of varenicline on major adverse liver outcomes in alcohol‐associated liver disease: An exploratory analysis
  di: Pojsakorn Danpanichkul, et al.
  Pubblicazione: (2025)